Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide to Oral and Intravenous Formulations
Circulation
.
2024 Nov 18.
doi: 10.1161/CIRCULATIONAHA.124.072949.
Online ahead of print.
Authors
Andrew P Ambrosy
1
,
Daniel Bensimhon
2
,
Galina Bernstein
3
,
Brian Kolski
4
,
Joel Neutel
5
,
Benjamin Esque
6
,
Eric Adler
7
Affiliations
1
Kaiser Permanente San Francisco Medical Center, San Francisco, CA; Kaiser Permanente Northern California (KPNC) Division of Research, Pleasanton, CA.
2
Cone Health Greensboro, NC; Ventricle Health Greensboro, NC.
3
Azure Delta Consulting, Thornhill, Ontario, Canada.
4
Ventricle Health Greensboro, NC.
5
Orange County Research Center, Lake Forest, CA.
6
Corstasis Therapeutics Inc. Henderson, NV.
7
University of California, San Diego Medical Center, San Diego, CA.
PMID:
39555978
DOI:
10.1161/CIRCULATIONAHA.124.072949
No abstract available
Publication types
Letter